A case with unexplained weight loss the underlying cause is aluminum toxicity

Aluminum, is the third most common element in the earth and has a significant toxic effects for humans. Although Al toxicity has been generally reported in dialysis population, it has been demonstrated elevated concentrations of Al was also toxic to non-dialyzed individuals, especially who is working in metal industry. Al toxicity mainly affects nervous system, musculoskeletal system, hematopoietic system and endocrine system. We presented a case who had severe weight loss, memory impairment and had a history of drinking well water. Complete blood count elicited normocytic anemia and other laboratory results proved low basal cortisol level. The toxicological analysis of water and patient’s blood sample revealed high Al level, we started desferrioxamine chelation and hydrocortisone replacement. After six month-therapy, anemia ameliorated and cognitive dysfunction was improved. Al toxicity should be thought as a possible diagnosis when a patient presents with unexplained anemia, weight loss, early onset dementia or personality changes.


1. Crisponi G, Dean A, Di Marco V, et al. Different approaches to the study of chelating agents for iron and aluminium overload pathologies. Coord Chem Rev. 2012;256:89–104

2. Azik FM, Ekim M, Sakallioglu O, et al. A different interaction between parathyroid hormone, calcitriol and serum aluminum in chronic kidney disease; a pilot study. Intl Urol Nephrol. 2011;467–70.

3. Willhite CC, Karyakina NA, Yokel RA, et al. Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts. Crit Rev Toxicol. 2014;44(Suppl 4):1-80.

4. Klotz K, Weistenhöfer W, Neff F, et al. The Health Effects of Aluminum Exposure. Dtsch Arztebl Int. 2017;114:653-9.

5. Mailloux RJ, Bériault R, Lemire J, et al. The tricarboxylic acid cycle, an ancient metabolic network with a novel twist. PLoS One. 2007;2:e690.

6. Krewski D, Yokel RA, Nieboer E, et al. Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J Toxicol Environ Health B Crit Rev. 2007;10 Suppl 1(Suppl 1):1-269. Erratum in: J Toxicol Environ Health B Crit Rev. 2008;11:147.

7. Şemen S, Mercan S, Yayla M, et al. Elemental composition of green coffee and its contribution to dietary intake. Food chemistry. 2017;215:92-100.

8. Parkinson IS, Ward MK, Kerr DN. Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis. J Clin Pathol. 1981;34:1285-94.

9. Kiesswetter E, Schaeper M, Buchta M, et al. Longitudinal study on potential neurotoxic effects of aluminium: I. Assessment of exposure and neurobehavioural performance of Al welders in the train and truck construction industry over 4 years. Int Arch Occup Environ Health. 2007;81:41–67.

10. Rosenlof K, Fyhrquist F, Tenhunen R. Erythropoietin, aluminum and anemia in patients on hemodialysis. Lancet. 1990;1:247–9.

11. Reusche E, Lindner B, Arnholdt H. Widespread aluminium deposition in extracerebral organ systems of patients with dialysis-associated encephalopathy. Virchows Archiv. 1994;424.

12. Díaz‐Corte C, Fernández‐Martín JL, Barreto S, et al. Effect of aluminium load on parathyroid hormone synthesis. Nephrol Dialysis Transplant. 2001;16:742-5

13. Orihuela, D. Aluminium effects on thyroid gland function: Iodide uptake, hormone biosynthesis and secretion. Journal of Inorganic Biochemistry. 2011;105:1464–8.

Kaynak Göster